2025年软骨成形术全球市场报告

预计未来几年软骨成形术市场规模将强劲成长。到 2029 年，这一数字将成长至 184.3 亿美元，复合年增长率为 5.9%。预测期内的成长可归因于再生医学的整合、对门诊手术的关注、新型生医材料的引入、肌肉骨骼疾病的增加以及老年人口的扩大。预测期内的关键趋势包括復健技术整合、关节镜技术、软骨修復和再生、手术器械创新以及导航系统整合。

预计关节相关疾病的激增将成为可预见的未来推动软骨成形术市场扩张的催化剂。这些疾病涵盖一系列影响关节功能的健康问题，通常是由于关节过度使用或意外或运动相关事件等突然受伤造成的。软骨成形术透过修復关节内受损的软骨来治疗这些关节相关疾病。 《柳叶刀》于 2023 年 8 月发布的最新资料显示，英国的痛风（一种影响关节的发炎性关节炎）发生率正在上升。诊断率从 2021 年 3 月的每 1,000 名成年人 1.40 人增加到 2022 年 3 月的每 1,000 名成年人 1.44 人。此外，美国疾病管制与预防美国(CDC) 在 2023 年 6 月的预测估计，到 2040 年，大约有 7,840 万（25.9%）18 岁及以上的美国成年人将被医生诊断出患有关节炎 (BRFSS)。因此，关节相关疾病盛行率的上升正在推动软骨成形术市场的成长轨迹。

膝关节手术的增加预计将加速未来软骨成形术市场的成长。膝关节手术是指针对膝关节的手术干预，以解决影响膝关节功能的各种状况、损伤和疾病。软骨成形术是一种专注于修復和再形成关节内受损软骨的外科手术，特别适用于膝关节相关治疗。尤其是美国国家医学图书馆的资料显示，2022年在1,150多家医疗机构进行的髋关节和膝关节手术总数将比2020年大幅增加18.3%，总合240万例。此外，同一资讯来源2023 年 1 月的预测显示了一个惊人的预测：到 2040 年，全膝关节置换术(TKA) 将激增 139%，到 2060 年将激增 469%。随着膝关节手术的增加，对软骨成形术的需求也将增加，进而推动软骨成形术市场的成长动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 世界软骨成形术PESTEL分析（政治、社会、技术、环境、法律因素、促进因素、抑制因素）
• 最终用途产业分析
• 全球软骨成形术市场：成长率分析
• 全球软骨成形术市场表现：规模与成长，2019-2024
• 全球软骨成形术市场预测：2024-2029 年及 2034 年规模与成长
• 全球软骨成形术总目标市场（TAM）

第六章市场区隔

• 全球软骨成形术市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 射频消融软骨成形术
• 配戴软骨成形术
• 软骨成形术
• 半月软骨修復
• 组织切除
• 其他类型
• 全球软骨成形术市场（依解剖学、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
• 膝盖
• 肩膀
• 时髦的
• 其他解剖学
• 全球软骨成形术市场：按设备、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 刮鬍刀
• 射频设备
• 关节镜
• 其他设备
• 全球软骨成形术市场：依最终用途、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 整形外科诊所
• 学术研究
• 其他用途
• 全球软骨成形术市场、射频消融术软骨成形术细分市场、按类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 射频消融术
• 低频消融
• 全球软骨成形术市场、消融性软骨成形术细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 机械磨损
• 关节镜擦伤
• 全球软骨成形术市场、髌骨软骨成形术细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 开放式膝盖骨软骨成形术
• 关节镜膝盖骨成形术
• 全球软骨成形术市场，依半月软骨修復细分，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 缝合技术
• 半月软骨
• 全球软骨成形术市场、组织切除细分、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 关节镜创术
• 开放清创术
• 全球软骨成形术市场，依类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 微骨折技术
• 自体软骨移植术

第七章 区域和国家分析

• 全球软骨成形术市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球软骨成形术市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 软骨成形术市场：竞争格局
• 软骨成形术市场：公司简介
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Osiris Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Medtronic Public Limited Company
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• Sigma-Aldrich Corporation
• Arthrex Inc.
• Bio-Rad Laboratories Inc
• QIAGEN NV
• CONMED Corporation
• Promega Corporation
• Organogenesis Holdings Inc.
• Bioventus LLC
• RTI Surgical Holdings Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年软骨成形术市场：哪些国家将带来新机会
• 2029年软骨成形术市场：细分领域带来新机会
• 2029年软骨成形术市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Chondroplasty is a surgical procedure designed to repair and reshape damaged cartilage within a joint, commonly performed to alleviate pain and improve joint function in cases of cartilage damage caused by conditions such as osteoarthritis or traumatic injuries.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroplasty market size has grown strongly in recent years. It will grow from $13.77 billion in 2024 to $14.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $18.43 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

Leading companies in the chondroplasty market are advancing the development of autologous chondrocyte-based therapies to improve cartilage repair by leveraging patients' own cells, thereby minimizing immune rejection and encouraging natural regeneration. Autologous chondrocytes, which are cartilage cells harvested from a patient's body (typically from a non-weight-bearing area of the joint), provide a personalized approach to treatment. For example, in August 2024, Vericel Corporation, a U.S.-based biopharmaceutical company, gained FDA approval for its MACI Arthro (Matrix Autologous Chondrocyte Implantation), now commercially available. This innovation in knee cartilage defect treatment allows orthopedic surgeons to conduct the procedure through minimally invasive incisions using specialized instruments, offering a less invasive alternative to traditional methods. This approach is anticipated to improve patient recovery and reduce post-operative complications.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroplasty Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chondroplasty ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chondroplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
• 2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
• 3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
• 4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses
• Subsegments:
• 1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation; Low-Frequency Ablation
• 2) By Abrasion Chondroplasty: Mechanical Abrasion; Arthroscopic Abrasion
• 3) By Patellar Chondroplasty: Open Patellar Chondroplasty; Arthroscopic Patellar Chondroplasty
• 4) By Meniscal Repair: Suturing Techniques; Meniscal Allograft Transplantation
• 5) By Tissue Removal: Arthroscopic Debridement; Open Debridement
• 6) By Other Types: Microfracture Techniques; Osteochondral Autograft Transplantation
• Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Osiris Therapeutics Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chondroplasty Market Characteristics

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chondroplasty Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chondroplasty PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chondroplasty Market Growth Rate Analysis
• 5.4. Global Chondroplasty Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chondroplasty Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chondroplasty Total Addressable Market (TAM)

6. Chondroplasty Market Segmentation

• 6.1. Global Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation Chondroplasty
• Abrasion Chondroplasty
• Atellar Chondroplasty
• Meniscal Repair
• Tissue Removal
• Other Types
• 6.2. Global Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Knee
• Shoulder
• Hip
• Other Anatomies
• 6.3. Global Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Shavers
• Radiofrequency Devices
• Arthroscope
• Other Equipments
• 6.4. Global Chondroplasty Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Orthopedic Clinics
• Academic Research
• Other End Uses
• 6.5. Global Chondroplasty Market, Sub-Segmentation Of Radiofrequency Ablation Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Frequency Ablation
• Low-Frequency Ablation
• 6.6. Global Chondroplasty Market, Sub-Segmentation Of Abrasion Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Abrasion
• Arthroscopic Abrasion
• 6.7. Global Chondroplasty Market, Sub-Segmentation Of Patellar Chondroplasty, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Patellar Chondroplasty
• Arthroscopic Patellar Chondroplasty
• 6.8. Global Chondroplasty Market, Sub-Segmentation Of Meniscal Repair, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Suturing Techniques
• Meniscal Allograft Transplantation
• 6.9. Global Chondroplasty Market, Sub-Segmentation Of Tissue Removal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arthroscopic Debridement
• Open Debridement
• 6.10. Global Chondroplasty Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microfracture Techniques
• Osteochondral Autograft Transplantation

7. Chondroplasty Market Regional And Country Analysis

• 7.1. Global Chondroplasty Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chondroplasty Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chondroplasty Market

• 8.1. Asia-Pacific Chondroplasty Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chondroplasty Market

• 9.1. China Chondroplasty Market Overview
• 9.2. China Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chondroplasty Market

• 10.1. India Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chondroplasty Market

• 11.1. Japan Chondroplasty Market Overview
• 11.2. Japan Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chondroplasty Market

• 12.1. Australia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chondroplasty Market

• 13.1. Indonesia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chondroplasty Market

• 14.1. South Korea Chondroplasty Market Overview
• 14.2. South Korea Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chondroplasty Market

• 15.1. Western Europe Chondroplasty Market Overview
• 15.2. Western Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chondroplasty Market

• 16.1. UK Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chondroplasty Market

• 17.1. Germany Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chondroplasty Market

• 18.1. France Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chondroplasty Market

• 19.1. Italy Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chondroplasty Market

• 20.1. Spain Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chondroplasty Market

• 21.1. Eastern Europe Chondroplasty Market Overview
• 21.2. Eastern Europe Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chondroplasty Market

• 22.1. Russia Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chondroplasty Market

• 23.1. North America Chondroplasty Market Overview
• 23.2. North America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chondroplasty Market

• 24.1. USA Chondroplasty Market Overview
• 24.2. USA Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chondroplasty Market

• 25.1. Canada Chondroplasty Market Overview
• 25.2. Canada Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chondroplasty Market

• 26.1. South America Chondroplasty Market Overview
• 26.2. South America Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chondroplasty Market

• 27.1. Brazil Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chondroplasty Market

• 28.1. Middle East Chondroplasty Market Overview
• 28.2. Middle East Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chondroplasty Market

• 29.1. Africa Chondroplasty Market Overview
• 29.2. Africa Chondroplasty Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chondroplasty Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chondroplasty Market, Segmentation By Equipment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chondroplasty Market Competitive Landscape And Company Profiles

• 30.1. Chondroplasty Market Competitive Landscape
• 30.2. Chondroplasty Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Osiris Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Chondroplasty Market Other Major And Innovative Companies

• 31.1. Medtronic Public Limited Company
• 31.2. Stryker Corporation
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. B. Braun Melsungen AG
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. Smith & Nephew plc
• 31.7. Sigma-Aldrich Corporation
• 31.8. Arthrex Inc.
• 31.9. Bio-Rad Laboratories Inc
• 31.10. QIAGEN N.V.
• 31.11. CONMED Corporation
• 31.12. Promega Corporation
• 31.13. Organogenesis Holdings Inc.
• 31.14. Bioventus LLC
• 31.15. RTI Surgical Holdings Inc.

32. Global Chondroplasty Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chondroplasty Market

34. Recent Developments In The Chondroplasty Market

35. Chondroplasty Market High Potential Countries, Segments and Strategies

• 35.1 Chondroplasty Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chondroplasty Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chondroplasty Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer